1. Survival trends in gastric cancer patients between 1987 and 2016: a population-based cohort study in Finland

   • Urgena Maharjan
   • Joonas H. Kauppila

   Original Article Open access 07 August 2022 Pages: 989 - 1001

   

2. ADAMTS10 inhibits aggressiveness via JAK/STAT/c-MYC pathway and reprograms macrophage to create an anti-malignant microenvironment in gastric cancer

   • Junyi Zhou
   • Tuoyang Li
   • Zuli Yang

   Original Article 04 August 2022 Pages: 1002 - 1016

   

3. Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma

   • Wei Wang
   • Liu-Fang Ye
   • De-Shen Wang

   Original Article Open access 29 July 2022 Pages: 1017 - 1030

   

4. The feasibility and safety of endoscopic submucosal dissection of gastric lesions larger than 5 cm

   • Hideyuki Chiba
   • Ken Ohata
   • Tohru Goto

   Original Article 25 July 2022 Pages: 1031 - 1038

   

5. Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study

   • Hyung-Don Kim
   • Jong Seok Lee
   • Yoon-Koo Kang

   Original Article 03 August 2022 Pages: 1039 - 1049

   

6. Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study

   • Jiayi Zhang
   • Yanfen Cui
   • Xiaotang Yang

   Original Article 06 August 2022 Pages: 1050 - 1059

   

7. Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial

   • Cas de Jongh
   • Lianne Triemstra
   • the LOGICA Study Group

   Original Article Open access 14 September 2022 Pages: 1060 - 1072

   

8. Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001)

   • Takeshi Kawakami
   • Junki Mizusawa
   • Masanori Terashima

   Original Article Open access 29 June 2022 Pages: 1073 - 1081

   

9. A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001–2013)

   • Yoshihiro Kakeji
   • Takashi Ishikawa
   • Registration Committee of the Japanese Gastric Cancer Association

   Original Article 05 July 2022 Pages: 1082 - 1093

   

10. International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study

    • Geoffrey Roberts
    • Patrick R. Benusiglio
    • the LAP-TG Study Group

    Original Article 13 July 2022 Pages: 1094 - 1104

11. Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population—on behalf of the Italian Research Group for Gastric Cancer

    • Pietro Maria Lombardi
    • D. Bernasconi
    • The Italian Research Group for Gastric Cancer (GIRCG)

    Original Article 21 July 2022 Pages: 1105 - 1116

    

12. Marked improvement of severe reflux esophagitis following proximal gastrectomy with esophagogastrostomy by the right gastroepiploic vessels-preserving antrectomy and Roux-en-Y biliary diversion

    • Yudai Hojo
    • Tatsuro Nakamura
    • Hisashi Shinohara

    Case Report 07 July 2022 Pages: 1117 - 1122

    

13. Impact of body composition on survival of PD-1/PD-L1-treated metastatic gastro-esophageal junction/gastric cancer

    • C. Morelli
    • V. Formica
    • HT. Arkenau

    Letter to the Editor 02 July 2022 Pages: 1123 - 1124

14. Comment on: “Internal hernia after gastrectomy for gastric cancer in minimally invasive surgery era,” Gastric Cancer, 2019 Feb 13, by Kang et al

    • Xinxin Shao
    • Yantao Tian

    Letter to the Editor 04 August 2022 Pages: 1125 - 1126

15. Recurrence of gastric cancer caused by implantation of tumor cells after percutaneous transesophageal gastrostomy

    • Teppei Kamada
    • Hironori Ohdaira
    • Yutaka Suzuki

    Letter to the Editor 25 August 2022 Pages: 1127 - 1128

16. Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer: a methodology issue

    • Wen-Li Zhang
    • Tao Cui

    Letter to the Editor 03 September 2022 Pages: 1129 - 1130

17. PD-L1 IHC testing: issues with interchangeability evidence based on laboratory-developed assays of unknown analytical performance

    • Emina Emilia Torlakovic

    Letter to the Editor 26 September 2022 Pages: 1131 - 1132

18. Reply to: Letter to editor on the article “Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy”

    • Joe Yeong
    • Chong Boon Teo
    • Raghav Sundar

    Letter to the Editor 24 September 2022 Pages: 1133 - 1135

    

19. Correction to: DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer

    • Zheng Li
    • Huizi Lei
    • Jia Yu

    Correction 22 September 2022 Pages: 1136 - 1138

    

20. Correction to: Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling

    • Qing Li
    • Wei Wu
    • Honggang Yu

    Correction 10 September 2022 Pages: 1139 - 1141